Powder: -20°C for 3 years | In solvent: -80°C for 1 year
19R(20S)-EpDPA is an oxylipin and a metabolite of docosahexaenoic acid .1,2It is formed from DHA by various cytochrome P450 (CYP) isoforms in a stereoselective manner.219R(20S)-EpDPA (30 nM) prevents calcium-induced increases in the spontaneous beating of isolated neonatal rat cardiomyocytes (NRCMs).3
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 μg | 35 days | $ 98.00 | |
50 μg | 35 days | $ 195.00 | |
100 μg | 35 days | $ 363.00 | |
500 μg | 35 days | $ 1,600.00 |
Description | 19R(20S)-EpDPA is an oxylipin and a metabolite of docosahexaenoic acid .1,2It is formed from DHA by various cytochrome P450 (CYP) isoforms in a stereoselective manner.219R(20S)-EpDPA (30 nM) prevents calcium-induced increases in the spontaneous beating of isolated neonatal rat cardiomyocytes (NRCMs).3 |
Molecular Weight | 344.495 |
Formula | C22H32O3 |
CAS No. | 2242542-60-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
19R(20S)-EpDPA 2242542-60-3 19R(20S) EpDPA 19REpDPA 19R(20S)EpDPA inhibitor inhibit